Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Chemodex
Pristane
177
CHF
CHF 177.00
In stock
CDX-P0161-L02525 mlCHF 177.00
CDX-P0161-L100100 mlCHF 530.00
CDX-P0161-L250250 mlCHF 1'058.00
| Product Details | |
|---|---|
| Synonyms | 2,6,10,14-Tetramethylpentadecane; Norphytan |
| Product Type | Chemical |
| Properties | |
| Formula |
C19H40 |
| MW | 268.52 |
| CAS | 1921-70-6 |
| RTECS | RZ1880000 |
| Source/Host Chemicals | Synthetic. |
| Purity Chemicals | ≥98% (GC) |
| Appearance | Colourless liquid. |
| Solubility | Soluble in hexane, ether, petroleum ether, benzene, chloroform or carbon tetrachloride. Insoluble in water. |
| Identity | Determined by 1H-NMR. |
| Declaration | Manufactured by Chemodex. |
| Other Product Data |
Click here for Original Manufacturer Product Datasheet |
| InChi Key | XOJVVFBFDXDTEG-UHFFFAOYSA-N |
| Smiles | CC(C)CCCC(C)CCCC(C)CCCC(C)C |
| Shipping and Handling | |
| Shipping | AMBIENT |
| Short Term Storage | +4°C |
| Long Term Storage | +4°C |
| Handling Advice | Protect from light and moisture. |
| Use/Stability | Stable for at least 2 years after receipt when stored at +4°C. |
| Documents | |
| MSDS |
 Download PDF |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
Description
Pristane is a hydrocarbon oil adjuvant that is used as an inflammation-inducing agent to induce tumorigenesis in mice and to induce autoimmune diseases in rodents. As a rheumatoid arthritis-inducing agent, it is used in research to understand the pathogenesis of rheumatoid arthritis and lupus. It works as an immunological adjuvant for monoclonal antibody generation in mouse ascites. It is used as a lubricant, a transformer oil, an immunologic adjuvant, and an anti-corrosion agent, biological marker, plasmocytomas inducer and in production of monoclonal antibodies.
Product References
(1) S.J. Hopkins, et al.; Curr. Top. Microbiol. Immunol. 122, 213 (1985) | (2) J.P. Kints, et al.; J. Immunol. Methods 119, 241 (1989) | (3) L.R. Garrett, et al.; Chem. Biol. Interact. 81, 119 (1992) | (4) S.H. Lee, et al.; Mol. Cell Biochem. 110, 75 (1992) | (5) L.R. Garrett, et al.; Exp. Cell Res. 205, 416 (1993) | (6) S. Janz, et al.; Cancer Res. 55, 518 (1995) | (7) H.B. Richards, et al.; Curr. Top. Microbiol. Immunol. 246, 387 (1999) | (8) J. Holmberg, et al.; J. Immunol. 176, 1172 (2006) | (9) W.H. Reeves, et al.; Trends Immunol. 30, 455 (2009) | (10) E.C. Freitas, et al.; Clin. Rheumatol. 36, 2403 (2017)